Effect of Neostigmine on Gastroduodenal Motility in Patients With Suspected Gastrointestinal Motility Disorders

BACKGROUND: Acetylcholinesterase inhibitors (ACIs), e.g., neostigmine, are known to increase upper and lower gastrointestinal (GI) motility and are used to treat acute colonic pseudoobstruction. However, their effects on gastroduodenal motility in humans are poorly understood. Our hypotheses were th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurogastroenterol Motil
Asıl Yazarlar: Parthasarathy, Gopanandan, Ravi, Karthik, Camilleri, Michael, Andrews, Christopher, Szarka, Lawrence A., Low, Phillip A., Zinsmeister, Alan R, Bharucha, Adil E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4659742/
https://ncbi.nlm.nih.gov/pubmed/26387781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nmo.12669
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller